Daymark Wealth Partners LLC Trims Stock Position in HCA Healthcare, Inc. $HCA

Daymark Wealth Partners LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.3% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 3,579 shares of the company’s stock after selling 124 shares during the period. Daymark Wealth Partners LLC’s holdings in HCA Healthcare were worth $1,371,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its position in shares of HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. grew its position in shares of HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after acquiring an additional 587,036 shares during the period. Nuveen LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at about $569,217,000. Pacer Advisors Inc. grew its position in shares of HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the period. Finally, Nordea Investment Management AB boosted its holdings in HCA Healthcare by 6.8% in the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after buying an additional 59,163 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on HCA shares. Truist Financial lifted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a report on Monday. Morgan Stanley set a $425.00 price objective on HCA Healthcare in a report on Monday. Barclays lifted their price objective on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday. Jefferies Financial Group lifted their price objective on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Oppenheimer raised their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday. Fourteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Price Performance

HCA opened at $468.21 on Thursday. The firm has a market capitalization of $109.56 billion, a price-to-earnings ratio of 18.10, a price-to-earnings-growth ratio of 1.37 and a beta of 1.40. The company’s 50 day simple moving average is $418.76 and its two-hundred day simple moving average is $385.09. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $475.38.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.